PCK1 and colorectal carcinoma: Some previous studies also showed that miR-20a-3p, miR-636, and miR-7-5p targeted PCK1 in the PPAR pathway and the small-molecule compound, mersalyl, mediated OXA resistance in CRC; results are consistent with those of a previous study.